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Research Long lasting pain hypersensitivity following 
ligation of the tendon of the masseter muscle in 
rats: A model of myogenic orofacial pain
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Abstract
Background: A major subgroup of patients with temporomandibular joint (TMJ) disorders have masticatory muscle 
hypersensitivity. To study myofacial temporomandibular pain, a number of preclinical models have been developed to 
induce myogenic pain of the masseter muscle, one of the four muscles involved in mastication. The currently used 
models, however, generate pain that decreases over time and only lasts from hours to weeks and hence are not 
suitable for studying chronicity of the myogenic pain in TMJ disorders. Here we report a model of constant myogenic 
orofacial pain that lasts for months.
Results: The model involves unilateral ligation of the tendon of the anterior superficial part of the rat masseter muscle 
(TASM). The ligation of the TASM was achieved with two chromic gut (4.0) ligatures via an intraoral approach. 
Nocifensive behavior of the rat was assessed by probing the skin site above the TASM with a series of von Frey 
filaments. The response frequencies were determined and an EF50 value, defined as the von Frey filament force that 
produces a 50% response frequency, was derived and used as a measure of mechanical sensitivity. Following TASM 
ligation, the EF50 of the injured side was significantly reduced and maintained throughout the 8-week observation 
period, suggesting the presence of mechanical hyperalgesia/allodynia. In sham-operated rats, the EF50 of the injured 
side was transiently reduced for about a week, likely due to injury produced by the surgery. Somatotopically relevant 
Fos protein expression was indentified in the subnucleus caudalis of the spinal trigeminal sensory complex. In the 
same region, persistent upregulation of NMDA receptor NR1 phosphorylation and protein expression and increased 
expression of glial markers glial fibrillary acidic protein (astroglia) and CD11b (microglia) were found. Morphine (0.4-8 
mg/kg, s.c.) and duloxetine (0.4-20 mg/kg, i.p.), a selective serotonin-norepinephrine reuptake inhibitor, produced 
dose-dependent attenuation of hyperalgesia.
Conclusions: Ligation injury of the TASM in rats led to long-lasting and constant mechanical hypersensitivity of 
myogenic origin. The model will be particularly useful in studying the chronicity of myogenic pain TMJ disorders. The 
model can also be adapted to other regions of the body for studying pathology of painful tendinopathy seen in sports 
injury, muscle overuse, and rheumatoid arthritis.
Background
Temporomandibular joint (TMJ) disorders are often
associated with chronic pain conditions and therefore a
severe health problem. A major subgroup of patients with
TMJ disorders have masticatory muscle hypersensitivity
[1,2]. To study myofacial temporomandibular pain, a
number of models have been developed in the recent
decades to induce myogenic pain of the masseter muscle,
one of the four muscles involved in mastication. The alge-
sic agents hypertonic saline, glutamate, serotonin, capsai-
cin and nerve growth factor are injected into the masseter
muscle in humans [3-8]. The inflammatory agent com-
plete Freund's adjuvant (CFA) is injected into the rat
masseter to produce inflammatory hyperalgesia [9-11].
Injection of glutamate, capsaicin or mustard oil into the
masseter muscle produces peripheral sensitization and
mechanical hyperalgesia in rats [12-15]. These models
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have generated important information on neural mecha-
nisms of persistent pain associated with TMJ disorders.
The currently used models, however, are not suitable
for studying chronicity of the myogenic pain in TMJ dis-
orders, which is a deteriorating and devastating problem
for the patients. Most algesic agents when injected into
the masseter muscle only induce an effect that lasts for
minutes to hours [3-6,12,13]. Relative long lasting hyper-
algesia can be induced by injecting nerve growth factor
into the masseter in humans [7] and CFA into the rat
masseter [9,10], but the hyperalgesia decreases over time.
Nevertheless, the hyperalgesia following the nerve
growth factor and CFA treatment is resolved within 1-3
weeks, which is unlike the long persistency of chronic
pain seen in TMJ disorders.
Here we report a model of myogenic orofacial pain that
lasts for months. The model involves unilateral ligation of
the tendon of the anterior superficial part of the rat
masseter muscle (TASM), which is a distinct structure
arising from the lateral surface of the maxilla just poste-
rior to the suture of the maxilla and premaxilla [16]. Con-
striction injury was produced by the ligation, leading to
long-lasting and stable mechanical allodynia/hyperalgesia
that can be assessed through the cutaneous site overlying
the tendon.
Methods
Animals
Male Sprague-Dawley rats, ≈ 8-week old at the time of
surgery, were used (225-250 g, Harlan, Indianapolis, IN).
Ligation of the TASM was achieved via an intraoral
approach. Animals were anesthetized with pentobarbital
sodium (50 mg/kg i.p.). The rat was fixed on a table and
the head was supine. The mouth of the rat was kept open
with a retractor. On the left side, a three-mm long inci-
sion was made posterior-anteriorly along but just lateral
to the gingivobuccal margin in the buccal mucosa, begin-
ning immediately next to the first molar. The TASM was
gently freed from surrounding connective tissues and
clearly visualized. The tendon was tied with two chromic
gut (4.0) ligatures, 2-mm apart. The wound was checked
for hemostasis and the incision closed with three 4.0 silk
sutures. The sham-operated rats received the same pro-
cedure except that the tendon was not ligated. Changes in
g r o s s  be h a vi o r  a n d  bod y  w e i g h t  i n  o pe r a t e d  r a t s  w e r e
monitored and compared with that in naive rats. Stan-
dard hematoxylin and eosin (EMS, Hatfield, PA) staining
was performed to examine histological changes of the
TASM after ligation, including infiltration of immune
cells and morphology of the tendon tissue. For time
course of hyperalgesia, 14 rats were used for the TASM
ligation and sham groups, respectively. For local anesthe-
sia and analgesic drugs experiments, 5 rats were used for
each experimental group. For immunohistochemistry
and western blot experiments, 3-4 rats were used for each
group. All experiments were carried out in accordance
with the National Institute of Health Guide for the Care
and Use of Laboratory Animals (NIH Publications No.
80-23) and approved by the University of Maryland Den-
tal School Institutional Animal Care and Use Committee.
All efforts were made to minimize the number of animals
used and their suffering.
Behavioral testing
All behavioral tests were conducted under blind condi-
tions as described elsewhere [9,17]. A series of calibrated
von Frey filaments were applied to the skin above the
TASM. An active withdrawal of the head from the prob-
ing filament was defined as a response. Each von Frey fil-
ament was applied 5 times at intervals of a few sec. The
response frequencies [(number of responses/number of
stimuli) × 100%] to a range of von Frey filament forces
were determined and a stimulus-response frequency (S-
R) curve plotted. After a non-linear regression analysis,
an EF50 value, defined as the von Frey filament force (g)
t h a t  p r o d u c e s  a  5 0 %  r e s p o n s e  f r e q u e n c y ,  w a s  d e r i v e d
from the S-R curve (Prism, GraphPad). We used EF50 val-
ues as a measure of mechanical sensitivity. A leftward
shift of the S-R curve [9,18,19], resulting in a reduction of
EF50, occurred after ligation of the TASM. This shift of
the curve suggests the presence of mechanical hyperalge-
sia and allodynia since there was an increase in response
to suprathreshold stimuli and a decreased response
threshold for nocifensive behavior.
Immunohistochemistry
At 3 d, 2 w and 8 w after ligation, rats were behaviorally
tested to identify tendon ligation-induced mechanical
hyperalgesia/allodynia, and then deeply anesthetized
with pentobarbital sodium (100 mg/kg, i.p.) and perfused
transcardially with 4% paraformaldehyde in 0.1 M phos-
phate buffer at pH 7.4. Naive rats and rats at 3 d and 2 w
after sham operation were also perfused. A tissue block
including a 2-mm segment at the caudal trigeminal sub-
nucleus caudalis (Vc, 3-5 mm caudal to the obex) was dis-
sected. This tissue block includes the caudal laminated Vc
and C1 upper cervical spinal cord, the major component
of the medullary dorsal horn. The brain stem block was
post-fixed and transferred to 25% sucrose (w/v) for cryo-
protection. Thirty micrometer-thick coronal sections of
the brainstem were cut with a cryostat at -20°C. Free-
floating sections were incubated with antibodies over-
night with 1-3% relevant normal sera. For Fos-like immu-
noreactivity (LI), after washes in PBS, the sections were
incubated with biotinylated secondary IgG (Vector,
1:400) and then with avidin and biotinylated horseradish
peroxidase complex (Vector, 1:100). The tissue sections
are finally reacted with 0.05% diaminobenzidine dihydro-Guo et al. Molecular Pain 2010, 6:40
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chloride (Sigma) in 0.1 M PB containing 0.003% hydrogen
peroxide for 3-6 min. For fluorescence staining (phospho-
rylation at serine 896 of the NR1 subunit, P-NR1; GFAP,
glial fibrillary acidic protein; CD11b, cluster of differenti-
ation 11b; NeuN), the sections were incubated with
Streptavidin-Alexa Fluor 568 or 488 (1:600, Molecular
Probes, Eugene, OR) for 1 h. The sections were then incu-
bated for 2 h in solutions containing species-specific sec-
ondary antibodies coupled to Cy3, Alexa 568 or Alexa
488. After washes in PBS, all sections were mounted on
gelatin-coated slides and coverslipped with Vectashield
(Vector Laboratories). Images were collected sequentially
using a Nikon fluorescence microscope and a charge-
coupled device camera controlled by SPOT software.
Adobe Photoshop (version CS4) was used for image crop-
ping and adjustment. Immunostaining control studies
were performed by omission of the primary or secondary
antibodies, and by adsorption with an excess (10 μg/ml)
of the respective antigens.
Western blot
The rats were anesthetized with isoflurane (3%) and
quickly decapitated. The same block of caudal brainstem
tissues as that for immunohistochemistry was collected.
The tissue block was turned coronally and the superficial
portion of the Vc was harvested by taking punches with a
15-gauge puncture needle. The tissues were homoge-
nized in solubilization buffer (50 mM Tris.HCl, pH8.0;
150 mM NaCl, 1 mM EDTA, 1% NP40, 0.5% deoxycholic
acid, 0.1% SDS, 1 mM Na3VO4, 1 U/ml aprotinin, 20 μg/
ml leupetin, 20 μg/ml pepstatin A). The homogenate was
centrifuged at 20,200 × g for 10 min at 4°C. The superna-
tant was removed. The protein concentration was deter-
mined using a detergent-compatible protein assay with a
bovine serum albumin standard. Each sample contains
proteins from one animal. The proteins (50 μg) were sep-
arated on a 7.5% SDS-PAGE gel and blotted to a nitrocel-
lulose membrane (Amersham Biosciences, Arlington
Heights, IL). The blots were blocked with 5% milk in tris-
buffered saline (TBS) buffer and then incubated with the
respective antibody. The membrane was washed with
TBS and incubated with anti-goat or mouse IgG (1:3000,
Santa Cruz Biotechnology, Santa Cruz, CA). The immu-
noreactivity was detected using Enhanced Chemilumi-
nescence (ECL, Amersham). The loading and blotting of
the amount of protein was verified by reprobing the
membrane with anti-β-actin antiserum (Sigma) and with
Coomassie blue staining.
Drugs and antibodies
The following drugs and antibodies were purchased from
commercial sources: Morphine sulfate salt pentahydrate
(Sigma, St. Louis, MO), dissolved in physiological saline
(0.09%); lidocaine (Henry Schein, Melville, NY); anti-Fos
antibody (EMD Biosciences, San Diego, CA) anti-GFAP ,
anti-NR1, anti-P-ser896 NR1 and anti-NeuN antibodies
(Millipore-Chemicon, Temecula, CA), and anti-CD11b
(clone OX-42) (AbD Serotec, Raleigh, NC). Duloxetine
(dissolved in 50% H2O/50% hydroxypropyl-β-cyclodex-
trin, Sigma) was provided by Eli Lilly and Company (Indi-
anapolis, IN). Drug doses are expressed as milligram salt
per kilogram body weight (mg/kg). The injection volume
was 1 ml/kg for systemic administration.
Data analysis
Data are presented as mean (95% confidence interval) for
EF50s and mean ± S.E.M. for other data. Statistical com-
parisons were made by the use of ANOVA with Fisher's
PLSD test for post-hoc analysis. Non-parametric statis-
tics were used for comparing EF50s (Kruskal-Wallis,
Mann-Whitney). Alternate sections were used for quanti-
fying Fos-positive neurons in the Vc-C1. Means of three
s e c t i o n s  f r o m  e a c h  a n i m a l  w e r e  u s e d  t o  d e r i v e  g r o u p
means. For western blot analysis, the ECL-exposed films
or gel images were digitized and densitometric quantifi-
cation of immunoreactive cDNA bands was carried out
using UN-SCAN-IT gel (ver. 5.3, Silk Scientific Inc.,
Orem, UT). The relative protein or mRNA levels were
obtained by comparing the respective specific band to the
β-actin control from the same membrane or gels. The
deduced ratios were further normalized to that of the
naive rats on the same membrane and illustrated as per-
centage of the naïve controls. For animals that were sub-
ject to repeated testing, ANOVA with repeated measures
was used with time as a within animal effect. P < 0.05 was
considered significant for all cases.
Results
Ligation injury of the tendon of the masseter muscle
The rat masseter muscle consists of four parts: anterior
and posterior superficial, and anterior and posterior deep
[16]. The anterior superficial part of the rat masseter
muscle has a strong slender tendon that is easily
approachable from the intraoral space (Fig. 1). We took
advantage of this distinct anatomical feature to produce
ligation injury of the TASM. Two chromic gut ligatures
were placed and tied around to the TASM as indicated in
Fig. 1a. Hematoxylin and eosin staining of the TASM
shows points of depression by the ligatures and disrupted
and disarrayed collagen fiber bundles (Fig. 1b). Com-
pared to naive rats, adhesive bands of collagen fibers
formed at the level of ligation (Fig. 1b). There was infiltra-
tion of inflammatory cells into the injured tendon, exam-
ined at 3 d and 2 w after ligation. Clusters of
inflammatory cells mixed with tenocytes were found
adjacent to the traumatized segment (Fig. 1b). Infiltrated
leukocytes were also seen in the muscle adjacent to the
tendon (not shown). At 8 w after ligation, no inflamma-Guo et al. Molecular Pain 2010, 6:40
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tory cells were observed in the ligated tendon and there is
scar formation in the injured area with rounded teno-
cytes clusters (not shown).
To assess the effect of intraoral surgery on general
health of the animals, the growth rate of the animals was
compared between different groups by monitoring body
weight. We first determined that the growth curve of
incoming naive rats (n = 6) was consistent with the
growth chart of Sprague Dawley rats [20] (Fig. 1c). The
growth curves were then compared between naive, ten-
don-ligated (n = 14) and sham-operated (n = 14) animals.
The results indicate that the operated rats had similar
growth rate with that of the naive rats within two weeks
after the surgery. At 4-8 weeks after surgery, rats receiv-
ing tendon ligation showed slowed body growth (p <
0.01) while the sham-operated rats were able to maintain
normal body weight as compared to naive rats and the
general Sprague-Dawley population (Fig. 1c). These
results suggest that, with delayed onset, the tendon liga-
tion injury had a long-lasting impact on the rat's growth.
The rats groomed the area above the tendon ligation less
within a few days of surgery but otherwise displayed nor-
mal locomotor activity, explored their environment, and
interacted with other rats.
Persistent behavioral hyperalgesia after tendon ligation
Following TASM ligation, the EF50 of the injured side was
significantly reduced (Fig. 2a), indicating the develop-
ment of mechanical hyperalgesia/allodynia. The reduc-
tion of EF50 was significant (p < 0.001, n = 14) at the first
test (3 d post ligation) and the hyperalgesia/allodynia
maintained throughout the observation period up to 8
Figure 1 Ligation of the masseter tendon of the rat. a. Drawing of rat skull and masseter muscle. The tendon (TASM) attachment of the anterior 
superficial portion of the masseter muscle to the right maxillary bone and the site of ligation with two ligatures are shown (arrows). b. Hematoxylin 
and eosin staining illustrating histology of the masseter tendon in naive (top) and TASM-ligated rats (TL-2w). Naive rat exhibited normal organized 
collagen fibers and uniformly distributed tenocytes (T, also see b1). Arrows in TL-2w panel indicate site of ligation injury. Note the depressed region 
produced by ligature (arrows). Compared to the naive rat, adhesive bands of collagen fibers were formed at the level of ligation (stars). Disruption of 
major collagen fiber bundle was found (arrowhead). Clusters of purple stained inflammatory cells mixed with tenocytes were seen (circle). Scale = 0.2 
mm. b1, b2. High power photomicrograph images showing examples of tenocytes in the normal tendon from a naive rat (b1) and examples of in-
flammatory cells are shown (b2). Mϕ, macrophage; M, monocyte; N, neutrophil. Scale = 0.02 mm. c. Comparison of body weight of the rats. Dashed 
line is adapted from Growth Chart of Harlan Sprague Dawley rat [20]. Note that the TL group had slowed growth at 12-16-week (4-8 weeks after injury) 
(p < 0.01, vs. naive rats). Error bars represent S.E.M.Guo et al. Molecular Pain 2010, 6:40
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weeks. There were no significant changes in EF50 on the
contralateral side, suggesting that the effect of ligation
was limited to the site of injury. In sham-operated rats (n
= 14), the EF50 on the injured side was reduced initially
after surgery. The reduction of EF50 in the sham rats was
smaller compared to the tendon-ligated rats and returned
to the baseline level by 7-10 days. The small and short-
lasting hypersensitivity after sham operation was likely
due to tissue injury produced by the surgical procedure,
similar to that seen in the sham operation of infraorbital
nerve injury [21].
We assessed the mechanical sensitivity of the tendon
through probing the overlying skin. Although deep tissue
primary afferents are activated by this mechanical pres-
sure, a problem with this approach is that cutaneous
afferents are also stimulated and may contribute to the
pain-pressure threshold [22]. To verify deep origin of
hyperalgesia after the tendon injury, we induced anesthe-
sia by infiltrating the local anesthetic lidocaine (4%, 0.05-
0.2 ml) into tissues surrounding the TASM or the overly-
ing skin in rats that had developed hyperalgesia after ten-
don ligation. The hyperalgesia was largely attenuated, as
shown by a significantly increase in EF50 (p < 0.001, n = 5),
when the TASM was anesthetized as compared to saline-
Figure 3 Effect of local anesthesia on mechanical allodynia and 
hyperalgesia after TASM ligation. To verify allodynia/hyperalgesia 
related to tendon injury, local anesthesia was induced in the intraoral 
site around the TASM or the overlying skin ipsilaterally by lidocaine 
(4%, 0.05-0.2 ml) in rats receiving tendon ligation and having devel-
oped allodynia/hyperalgesia. Compared to saline-treated rats (Saline-
Intraoral, n = 5), allodynia/hyperalgesia was significantly attenuated 
when lidocaine was infiltrated into the TASM site (Lido-Intraoral, n = 5) 
at 30 min after lidocaine (***, p < 0.001, vs. saline). Local anesthesia of 
the skin overlying TASM (Lido-Cutaneous, n = 5) did not affect hyper-
algesia. Note that some symbols are slightly shifted horizontally for 
clarity. Error bars represent 95% confidence intervals.
Figure 2 Mechanical hyperalgesia/allodynia following ligation of 
the masseter tendon. The orofacial skin site above the TASM was 
probed with a series of von Frey microfilaments. The EF50s were de-
rived from the respective stimulus-response frequency function curves 
and are plotted against time after surgery. A significant reduction of 
EF50 indicates increased mechanical sensitivity, or mechanical hyperal-
gesia and allodynia. Note log scales for the ordinate. Filled circles show 
group means and open circles indicate individual EF50 of the side ipsi-
lateral to injury. Error bars are 95% confidence intervals of EF50s. a. Rats 
receiving ligation of the TASM (n = 14). A significant reduction of EF50 
indicating significant mechanical allodynia occurred ipsilateral to inju-
ry at 3 d and was maintained through the 8-week period. There was no 
change in EF50 on the equivalent contralateral site. b. Sham-operated 
rats showed a temporary reduction of EF50 at 3 d ipsilateral to intraoral 
procedure (n = 14). *, p < 0.01 vs. contralateral site.Guo et al. Molecular Pain 2010, 6:40
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treated rats (Fig. 3). The effect of local anesthesia started
to wear off after 60 min (Fig. 3). In contrast, the tendon
injury-induced hyperalgesia was not affected when the
overlying skin testing site was anesthetized (n = 5) (Fig.
3). Thus, a reduction of EF50 at the testing site in tendon-
ligated rats reflects tenderness and increased sensitivity
o f  deep t is s ue .  T his is  c ons is t e n t  wit h pr evio us  r es ul ts
that masseter hyperalgesia was detectable when the over-
lying skin site was anesthetized [23].
Neuronal activation in the spinal trigeminal nucleus
W e  u s e d  F o s - L I  t o  a s s e s s  n e u r o n a l  a c t i v a t i o n  i n  t h e
trigeminal spinal nucleus after ligation of the TASM. Fos-
immunoreactive reaction product appeared as distinctive
light to dark brown staining in cellular nuclei. In the lam-
inated subnucleus caudalis and upper cervical dorsal
horn, Fos-positive cells were mainly clustered in the
medial-intermediate portion of superficial laminae on the
side ipsilateral to ligation (Fig. 4a). There were no signifi-
cant increases in Fos-LI in the Vc-C1 contralateral to the
injury (not shown). The distribution of Fos-LI is consis-
tent with somatotopy of the V3 input with a small V2
component. Few Fos-labeled neurons were found in lami-
nae III/IV and V/VI. The number of Fos-positive cells in
the superficial laminae was quantified. Compared to
naive animals (n = 3) where very few Fos-positive cells (<
5 cells/section) were seen (Fig. 4b,h), ligation of TASM
and sham injury induced a significant increase in the
number of Fos-labeled cells at 3 d after operation (p <
0.05, n = 3) (Fig. 4b,c,f). At 2 weeks after ligation, there
was still a significant increase in Fos-LI, although it was
reduced in magnitude compared to the 3 d time point (n
= 3). The Fos-LI returned to the naive level at 2 weeks in
sham-operated animals (Fig. 4b,g) (n = 3). At 8 weeks
after tendon ligation (n = 3), Fos-LI was at the naive level
in ligated animals (Fig 4b,e).
Activation of NMDA receptors and glia
NMDA receptor phosphorylation has been widely
accepted as an indication of synaptic plasticity and corre-
lates with the time course of persistent pain [24]. Tissue
injury induces NMDA receptor activation involving
phosphorylation of the NR1 and NR2 subunits in the spi-
nal dorsal horn [18,25,26]. The changes in phosphory-
lated NR1, the obligatory subunit of the NMDA receptor,
were quantified by Western blot (n = 3/4/group) in tis-
Figure 4 Fos protein expression in the spinal trigeminal nucleus after TASM ligation. a. Low power photomicrograph of a section of the upper 
cervical dorsal horn illustrating induction of Fos-LI in superficial laminae (dashed rectangle). Scale = 0.2 mm. b. Histogram illustrating mean number 
of Fos-positive neurons in superficial laminae of Vc-C1 ipsilateral to TASM ligation (TL). Naive rats were used as a control. *, p < 0.05 vs. naive, n = 3/
group. Error bars represent S.E.M. c-h. Examples of Fos-LI. All fields were taken and enlarged from a portion of medial-intermediate superficial dorsal 
horn as shown by the rectangle in a. Scale = 0.05 mm.Guo et al. Molecular Pain 2010, 6:40
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sues taken from the same region that showed increased
Fos-LI after tendon ligation. The results indicate that the
levels of P-NR1 increased by 200-400% of the naive level
in rats receiving tendon injury (p < 0.05-0.01) (Fig. 5a).
The increase in P-NR1 in sham rats was significant at 3 d
(p < 0.05, n = 3) but there was no significant change in P-
NR1 at 2 w after sham surgery (Fig. 5a). There was also a
time-dependent upregulation of the NR1 protein levels
(Fig. 5b). The neuronal localization of P-NR1 in Vc-C1
was verified with immunofluorescence. P-NR1-like stain-
ing was mainly in the cytoplasm of neurons (Fig. 6, also
see Guo 07). Compared to the naive rat, there was an
increase in P-NR1 immunostaining in the Vc-C1 superfi-
cial dorsal horn after tendon injury (Fig. 6a, left column:
TL-3 d and 2w). Sham-operated rat also showed an
increased P-NR1 immunostaining at 3 d (not shown).
Double immunostaining of P-NR1 with NeuN confirmed
that the increased NMDA receptor phosphorylation was
in neurons (Fig. 6b).
New evidence indicates that non-neuronal components
of the nervous system facilitate synaptic plasticity and
participate in chronic pain mechanisms [27]. Astroglia
Figure 5 Western immunoblot illustrating TASM-ligation-induced upregulation of NMDA receptors and glial markers. The dorsal Vc-C1 was 
punched out at various time points and total proteins isolated. Beta-actin was used as a loading control. An example of the blot is shown on top and 
the relative protein levels are shown in the bottom histogram. Note the increased levels of P-NR1, NR1 protein, GFAP and CD11b in TL rats at 3 d, 2w 
and 8w. Sham rats only showed the increases at 3 d after the procedure. *, p < 0.05; **, p < 0.01, vs. naive rats. #, p < 0.05; ##, p < 0.01, vs. sh-2w. N = 
3-4 for each time point. Error bars represent S.E.M.Guo et al. Molecular Pain 2010, 6:40
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and microglia, the two major glial cell types in the CNS,
exhibit an hyper-reactive phenotype after peripheral
injury and are believed to play a role in pain hypersensi-
tivity. We examined whether masseter tendon injury
induced glial hyperactivity in the spinal trigeminal
nucleus. The increase in GFAP, a marker of astrocyte, was
quantified by western blot. The tissues from the Vc-C1
dorsal horn ipsilateral to surgery were punched out and
total proteins isolated. As shown in Fig. 5c, the increase
in GFAP levels was seen at 3 d, 2 w and 8 w after ligation
(p < 0.01). Sham-operated rats showed a small increase in
GFAP at 3 d (p < 0.05, n = 3) but not at 2 w after surgery
(Fig. 5c). The masseter tendon ligation also upregulated
the levels of CD11b, a marker of activated microglia.
Western blot analysis showed that the pattern of increase
in CD11b was similar to that of GFAP (Fig. 5d). Utilizing
GFAP immunostaining, reactive astroglia were clearly
seen in the Vc-C1 after tendon ligation as compared to
naive rats (Fig. 6a, GFAP: TL-3 d and 2w). There was also
an increase in CD11b immunostaining after tendon liga-
tion (Fig. 6a, CD11b: TL-3 d and 2w).
Attenuation of hyperalgesia by analgesics
We finally verified the sensitivity of the TASM injury
model to morphine and duloxetine, the two agents that
are clinically used as analgesics and commonly used in
preclinical studies [28,29]. The effects of morphine and
duloxetine were evaluated in rats at 8 weeks after ligation
of the TASM when persistent mechanical hyperalgesia/
allodynia had developed (Fig. 2a). Morphine was injected
Figure 7 Effects of morphine and duloxetine on EF50s of rats at 8 
weeks after ligation of the TASM. The EF50s were below 1 g prior to 
administration of drugs, indicating the presence of mechanical allo-
dynia. a. Morphine was injected s.c. at 0.4, 4 and 8 mg/kg (1 ml/kg, n = 
5 per dose). Morphine produced significant and dose-dependent in-
creases in EF50s tested at 45 min after injection (ANOVA, P < 0.01). b. 
Duloxetine was injected i.p. at 0.4, 4, 10 and 20 mg/kg (1 ml/kg, n = 5 
per dose). Administration of duloxetine produced significant and 
dose-dependent increases in EF50s tested at 60 min after injection 
(ANOVA, P < 0.01).
Figure 6 Immunofluorescence staining of phosphoserine896-
NR1 (P-NR1), GFAP and CD11b in naive and TASM-ligated (TL) 
rats. a. Note increased immunostaining at 3 d and 2w after tendon li-
gation, suggesting NMDA receptor activation and glial hyperactivity. 
Scale = 0.025 mm. b. Localization of P-NR1 in Vc neurons at 3 d after 
tendon ligation. P-NR1 is shown as green fluorescence (Alexa Fluor 
488, left). NeuN is visualized with Cy3 (red, middle). Overlap of left and 
middle panels reveals cells that exhibit double fluorescence of NeuN 
(nucleus) and P-NR1 (cytoplasm) in the same neurons (right). Examples 
of double-labeled neurons are indicated by arrows. Scale = 0.05 mmGuo et al. Molecular Pain 2010, 6:40
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s.c. at 0.4, 4 and 8 mg/kg (1 ml/kg, n = 5 per dose). As
shown in Fig. 7a, subcutaneous administration of mor-
phine produced significant and dose-dependent increases
in EF50s tested at 45 min after injection (ANOVA, P <
0.01). Compared to pre-morphine EF50 of 0.45 g (95%
confidence interval: 0.38-0.53 g), 4 mg/kg of morphine
elevated EF50 to 20.9 g (13.1-33.4 g) (p < 0.01). The EF50
returned to the pre-morphine level at 90 min after injec-
tion. These results indicate that morphine produced a
moderate antihyperalgesic effect in the tendon injury
model. There was also a significant increase in EF50s on
the equivalent contralateral site after injection of 4 mg/kg
(p < 0.05) and 8 mg/kg (p < 0.01) morphine, confirming
the analgesic effect of morphine.
We next studied the effect of duloxetine, a serotonin-
norepinephrine reuptake inhibitor. Duloxetine was
injected i.p. at 0.4, 4, 10 and 20 mg/kg (1 ml/kg, n = 5 per
dose). As shown in Fig. 7b, intraperitoneal administration
of duloxetine produced significant and dose-dependent
increases in EF50s tested at 60 min after injection
(ANOVA, P < 0.01). Compared to pre-duloxetine EF50 of
0.54 g (0.44-0.66 g), 20 mg/kg of duloxetine elevated EF50
to 95.1 g (56.6-160.0 g) (p < 0.01). There was no signifi-
cant increase in EF50s on the equivalent contralateral site
after duloxetine.
Discussion
The major finding of the present study is that simple liga-
tion of one tendon of the rat masseter muscle, TASM, led
to long lasting and constant mechanical hyperalgesia/
allodynia. The hyperalgesia/allodynia was robust,
occurred as early as 3 d after ligation and was maintained
throughout the 8-week observation period. Correlated
and somatotopically relevant neurochemical changes
were identified in the spinal trigeminal nucleus after liga-
tion of the TASM. There was neuronal activation, as indi-
cated by induced Fos protein-LI in superficial laminae of
Vc-C1 where trigeminal nociceptive input is processed
and relayed. NMDA receptor expression and phosphory-
lation were upregulated, as well as GFAP and CD11b,
markers of astroglia and microglia, respectively. Clinically
used analgesics morphine and duloxetine attenuated
hyperalgesia/allodynia after TASM ligation, confirming
the feasibility of this model in evaluating new treatment
approaches for pain management in humans.
Chronic myogenic TMJ pain in humans often involves
muscles of mastication, among which masseter muscle
dysfunction involving its tendinous origin is frequently
seen [30,31]. Clinically, inflammation of the masseter
muscle at its attachment to the zygomatic arch is called
tenomyositis or tendomyositis, so named as human
masseter muscle fibers and layers of tendon alternate at
their attachment to the bone [30]. Similarly, chronic mus-
culo-tendinous pain of other body regions is often related
to inflammation of the tendon, or tendinitis (tendonitis).
It is also noted that chronic pain involving tendon condi-
tions including injury is not necessarily accompanied by
inflammatory responses [32,33]. For example, in a histo-
pathological study of the cases of tendon rapture in
humans, 97% of samples did not show signs of inflamma-
tion [34]. Currently, the term 'tendinopathy' is used to
describe conditions of tendon pathology, often with
chronic pain, without alluding to underlying pathology
[33,35]. Our histopathology results show that inflamma-
tory cells infiltrated into the tendon at 2 weeks after liga-
tion, indicating the presence of inflammation. There was
also signs of inflammation in the muscle adjacent to the
tendon, suggesting that the observed hyperalgesia/allo-
dynia also involve a muscle component. The inflamma-
tion of the tendon/muscle may explain the initiation of
hyperalgesia/allodynia after ligation injury. The tendon
ligation model developed in the present study attempts to
generate a pathological condition with prolonged orofa-
cial nociception of myogenic origin, relevant to myositis
of the masseter muscle or myopathies, in general.
Compared to existing preclinical models of myogenic
orofacial pain, the unique feature of the present model is
its constant and long lasting pain hypersensitivity, thus
making it suitable for studying chronicity of pain in TMJ
disorders. In addition to inflammation, ligation of the
tendon produces mechanical injury and leads to disrup-
tion and disarray of collagen fibers, and hypovasculariza-
tion. The tendinous attachment of the tendon may be
further damaged due to contraction, which is unavoid-
able during mastication. The tendon receives innervation
from cutaneous, muscular and peritendinous nerve
trunks, although most nerve fibers do not directly reach
the main body of the tendon except that Golgi organs
located at the junction of the tendon and the muscle
receive innervation from large myelinated nerve fibers
[33,36,37]. After ligation, networks of nerve fibers and
nerve endings on the surface of the tendon may be dam-
aged, which would likely involve unmyelinated nocicep-
tors and autonomic nerve terminals [36].
Ligation of the TASM may lead to biochemical changes
in and around the tendon. Cumulating evidence shows
that chronic tendinopathy is associated with altered
expression of local enzymes, cytokines, and neurotrans-
mitters and receptors [35]. Multiple isoforms of matrix
metalloproteinases (MMP) and tissue inhibitors of metal-
loproteinase are either up- or down regulated [35]. These
enzymes contribute to matrix remodeling of injured ten-
dons. However, they may also play a role in generating
pain in the tendon. For example, MMP9 that shows
increased expression in ruptured tendon has been associ-
ated with microglial activation and pain after nerve injury
in animal models [38]. Expression of inflammatory medi-Guo et al. Molecular Pain 2010, 6:40
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ators cyclooxygenase 2 [39] and interleukin-1 [40] are
increased in painful tendon, even without infiltration of
inflammatory cells. In tendinopathy patients, chemical
mediators of nociception, glutamate and substance P,
exhibit increased expression in tendon, along with
peripheral NMDA receptors [41-43]. Similarly, following
transection injury of the ligament, peptidergic innerva-
tion such as substance P and calcitonin gene-related pep-
tide-positive fibers were increased in epiligament tissues
in rabbits [44]. These chemical mediators are capable of
sensitizing peripheral nociceptors and initiate and main-
tain hyperalgesia [6,12].
Thus, the factors leading to constant pain after TASM
ligation involve cellular changes at the site of injury. They
include inflammatory responses, mechanical breakdown
of collagen fibers and damage of peripheral nociceptors
associated with sensory innervation of the TASM, and
changes in local tissue matrix enzymes and neurotrans-
mitters/receptors. The TASM ligation model provides a
convenient method to study peripheral neural and
immune mechanisms of myogenic pain in TMJ disorders.
Hyperexcitability of central pain processing circuitry
may also be involved in long lasting pain after TASM
injury. We have chosen a few markers to assess increased
excitability of the central trigeminal pain pathways after
TASM ligation. Fos protein expression, which is generally
absent under normal conditions, has been widely used as
a marker of nociceptive neuronal activation [45]. Persis-
tent Fos protein expression has been demonstrated after
TMJ inflammation in rats [46]. We identified neuronal
activation in the Vc-C1 dorsal horn, the first relay of
trigeminal nociceptive input, after TASM injury. The Fos-
LI is mainly distributed in the medial-intermediate por-
tion of the superficial laminae, corresponding to V3 input
with a V2 component. The masseter muscle is innervated
by the masseter nerve from V3 (mandibular nerve). Since
the TASM is inserted into the maxilla and tissues in the
V2 territory are also injured during ligation of the TASM,
V2 (maxillary)-related neuronal activation is observed.
Thus, the TASM ligation-induced neuronal activation is
somatotopically relevant. Selective induction of Fos-LI in
Vc-C1 neurons was consistent with initiation of behav-
ioral hyperalgesia after tendon and tissue injury and sug-
gests nociceptive activation of trigeminal pain pathways.
Significant Fos expression was seen at 3 d after ligation.
Fos-LI remained increased at 2 weeks, although the level
of expression was less than the 3 d time point. This pat-
tern of Fos protein induction is similar to that seen in the
TMJ inflammation model and may reflect reduced noci-
ceptive input as tissue repair is progressing. It is notable
that at 8 weeks after ligation, there was no significant
increase in Fos expression while intense hyperalgesia and
allodynia were still present. Interestingly, at 8 w after liga-
tion, no inflammatory cells were observed in the ligated
tendon, indicating that tissue inflammation had been
resolved. These results suggest that the central hyperex-
citability state has been previously established and can be
maintained by attenuated primary afferent nociceptive
input; or that other down stream targets are involved in
the maintenance of the hyperexcitability.
Our results showed enhanced NMDA receptor phos-
phorylation in trigeminal pain processing circuitry after
intraoral injury. The parallel upregulation of P-NR1 and
NR1 proteins suggests that de novo synthesized NR1 pro-
teins contribute to increased NR1 phosphorylation. Dif-
ferent from the time course of Fos protein expression
after TASM ligation, the NMDA receptor NR1 subunit
showed constant upregulation in protein translation and
phosphorylation throughout the observation period.
Astroglial and microglial markers also exhibited
increased expression at all time tested. These changes
parallel the long-lasting hyperalgesia seen after the ten-
don ligation and may also be maintained in the face of
attenuated primary nociceptive input or by other mecha-
nisms. Information from the sham control animals fur-
t h e r  c o n f i r m e d  t h a t  t h e  l e v e l s  o f  N M D A  r e c e p t o r
phosphorylation and expression of glial markers returned
to the control level at 2 weeks after the sham procedure
when hyperalgesia due to tissue injury in sham animals
had resolved. These results suggest that the TASM liga-
tion model shares some key neurochemical mechanisms
with other models of myogenic and neuropathic orofacial
pain in which neuron-glia-cytokine interactions play an
important role in central mechanisms of persistent orofa-
cial hyperalgesia [11,21,47-49]. These neurochemical
findings indicate that masseter tendon ligation induced
long-lasting changes in the trigeminal pain processing
circuitry. The parallel or coordinated neuronal and glial
responses correlated well with long lasting mechanical
hyperalgesia/allodynia after masseter tendon injury and
temporary hyperalgesia after intraoral tissue injury due to
the sham operation.
We did not observe hyperalgesia contralateral to the
ligation, although we did notice a mild hypersensitivity in
the ipsilateral TMJ region after TASM ligation (Unpub-
lished observation). This seems consistent with clinical
reports that 90% of patients with tenomyositis had a uni-
lateral disorder [31]. The CFA-induced masseter inflam-
mation model, however, produces hyperalgesia remote
from the site of inflammation [9,50]. After injecting a rel-
atively large dose of CFA into the masseter muscle, hype-
ralgesia spreads into the hindpaws of the rat or the robust
trigeminal hypersensitivity leads to distant motor activity
[ 5 0 ] .  W e  s p e c u l a t e ,  t h a t  c o m p a r e d  t o  t e n d o n  l i g a t i o n ,
CFA produces an intense inflammatory response that
directly activates muscle nociceptors and provides a
stronger nociceptive primary afferent input to the CNS.
Activation of central pain facilitatory pathways also leadsGuo et al. Molecular Pain 2010, 6:40
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to secondary hyperalgesia [9,19]. Assuming a further
diminished role of primary afferent input during the later
phase of tendon injury, it would be interesting to deter-
mine whether persistence of hyperalgesia seen in the
present model relies on a transition from peripheral to
central mechanisms. The maintained increase in the
expression of glial markers and postsynaptic NMDA
receptor phosphorylation that parallels the time course of
hyperalgesia lends support to this hypothesis.
Conclusions
We have developed an orofacial tendon injury model with
long lasting pain hypersensitivity of myogenic origin. The
T ASM is easily approachable and the model is easy to
produce. Mechanical hyperalgesia and allodynia of the
tendon can be assessed through probing facial skin and
are sensitive to clinically used analgesics. The model will
be particularly useful in studying the chronicity of pain
associated with TMJ disorders. It is worth noting that rats
with the tendon injury showed a delayed reduction of
body growth, suggesting an effect of the lasting intense
hyperalgesia on body health and different mechanisms
underlying responses at the early and late phases of ten-
don injury. Further, the model can also be adapted to
other regions of the body for studying pathology of pain-
ful tendinopathy seen in sports injury, muscle overuse,
and rheumatoid arthritis [51].
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